589 related articles for article (PubMed ID: 15250164)
21. Vasoactive properties of synthetic blood substitutes.
de Figueiredo LF
Medicina (B Aires); 1998; 58(4):403-10. PubMed ID: 9816703
[TBL] [Abstract][Full Text] [Related]
22. Artificial blood substitutes.
Schneider P
Transfus Sci; 1992 Jul; 13(3):357-70. PubMed ID: 10148132
[No Abstract] [Full Text] [Related]
23. Hemospan: design principles for a new class of oxygen therapeutic.
Vandegriff KD; Winslow RM
Artif Organs; 2009 Feb; 33(2):133-8. PubMed ID: 19178457
[TBL] [Abstract][Full Text] [Related]
24. Red cell substitutes.
Winslow RM
Semin Hematol; 2007 Jan; 44(1):51-9. PubMed ID: 17198847
[TBL] [Abstract][Full Text] [Related]
25. Current status of artificial oxygen carriers.
Spahn DR
Adv Drug Deliv Rev; 2000 Feb; 40(3):143-51. PubMed ID: 10837786
[TBL] [Abstract][Full Text] [Related]
26. [Current research on oxygen carriers for transfusion: hemoglobin solutions and fluorocarbon emulsions].
Labrude P
Ann Pharm Fr; 1992; 50(5-6):250-66. PubMed ID: 1307671
[TBL] [Abstract][Full Text] [Related]
27. Artificial oxygen carriers: a current review.
Henkel-Honke T; Oleck M
AANA J; 2007 Jun; 75(3):205-11. PubMed ID: 17591302
[TBL] [Abstract][Full Text] [Related]
28. Artificial Oxygen Carriers.
Malchesky PS
Artif Organs; 2017 Apr; 41(4):311. PubMed ID: 28397404
[No Abstract] [Full Text] [Related]
29. Artificial oxygen carriers.
Frietsch T; Lenz C; Waschke KF
Eur J Anaesthesiol; 1998 Sep; 15(5):571-84. PubMed ID: 9785073
[TBL] [Abstract][Full Text] [Related]
30. Current aspects in pharmacology of modified hemoglobins.
Palaparthy R; Wang H; Gulati A
Adv Drug Deliv Rev; 2000 Feb; 40(3):185-98. PubMed ID: 10837789
[TBL] [Abstract][Full Text] [Related]
31. Modified haemoglobins as oxygen-transporting blood substitutes.
Mallick A; Bodenham AR
Br J Hosp Med; 1996 Apr 3-16; 55(7):443-8. PubMed ID: 8730571
[TBL] [Abstract][Full Text] [Related]
32. Artificial O2 carriers: status in 2005.
Spahn DR; Kocian R
Curr Pharm Des; 2005; 11(31):4099-114. PubMed ID: 16378514
[TBL] [Abstract][Full Text] [Related]
33. Perfluorocarbon-based oxygen carriers: review of products and trials.
Castro CI; Briceno JC
Artif Organs; 2010 Aug; 34(8):622-34. PubMed ID: 20698841
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Hemoglobin-based oxygen carriers to stored human red blood cells.
Eastman AL; Minei JP
Crit Care Clin; 2009 Apr; 25(2):303-10, Table of Contents. PubMed ID: 19341910
[TBL] [Abstract][Full Text] [Related]
35. Blood substitutes as pharmacotherapies in clinical practice.
Jahr JS; Walker V; Manoochehri K
Curr Opin Anaesthesiol; 2007 Aug; 20(4):325-30. PubMed ID: 17620840
[TBL] [Abstract][Full Text] [Related]
36. Expectations and implications of blood sparing with hemoglobin based oxygen carriers.
Estep TN
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):93-105. PubMed ID: 17364474
[TBL] [Abstract][Full Text] [Related]
37. Polymer/hemoglobin assemblies: biodegradable oxygen carriers for artificial red blood cells.
Li T; Jing X; Huang Y
Macromol Biosci; 2011 Jul; 11(7):865-75. PubMed ID: 21312333
[TBL] [Abstract][Full Text] [Related]
38. Oxygen therapeutics: oxygen delivery without blood.
Stollings JL; Oyen LJ
Pharmacotherapy; 2006 Oct; 26(10):1453-64. PubMed ID: 16999656
[TBL] [Abstract][Full Text] [Related]
39. Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions.
Spahn DR
Crit Care; 1999; 3(5):R93-7. PubMed ID: 11094488
[TBL] [Abstract][Full Text] [Related]
40. Artificial Oxygen Carriers: Exactly How Close Are We to an Ultimate Product?
Simoni J
Artif Organs; 2017 Apr; 41(4):316-318. PubMed ID: 28397406
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
